Exelixis, Inc. is a company in the U.S. stock market and it is a holding in 136 U.S.-traded ETFs. EXEL has around 48.2M shares in the U.S. ETF market. The largest ETF holder of EXEL is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 9.32M shares. Investors may also find of interest that the ETF with the largest allocation to EXEL stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 3.90%. On average, U.S. ETFs allocate 0.37% of EXEL to their portfolios.

Additionally, EXEL is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EXEL as a holding is the First Trust Active Factor Mid Cap ETF (AFMC), with a return of --.